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A recombinant form of Escherichia coli DdlB (EcDdlB) has been prepared
and cocrystallized with ADP and d-alanyl-d-alanine to represent the ternary
complex of EcDdlB. Furthermore, EcDdlB has been cocrystallized under the
same conditions with the ligands ATP and d-alanyl-d-alanine, representing the
product-inhibited complex. The crystals belonged to space group P212121, with
unit-cell parameters a = 53.0, b = 97.6, c = 109.5 A˚ and a = 51.2, b = 97.8,
c = 110.1 A˚, respectively, and both contained two molecules in the asymmetric
unit. Complete data sets were collected to 1.5 and 1.4 A˚ resolution, respectively,
from single crystals under cryogenic conditions using synchrotron radiation.
1. Introduction
Peptidoglycan is a specific dynamic structure which constitutes a vital
component of the bacterial cell wall (Vollmer et al., 2008). The bio-
synthesis of peptidoglycan occurs in three distinct phases at different
locations and stages of the cell cycle. The initial cytoplasmic stage
sequentially assembles the peptidoglycan intermediates prior to their
translocation across the cell membrane. At the bacterial exoplasmic
surface subsequent transpeptidation and transglycosylation reactions
occur to produce mature cross-linked chains of peptidoglycan.
d-Alanyl-d-alanine ligase (Ddl) is a cytoplasmic enzyme specific to
peptidoglycan synthesis; it provides the d-alanyl-d-alanine dipeptide
substrate for MurF in the initial cytoplasmic phase of biosynthesis
(Neuhaus, 1962). The d-alanyl-d-alanine dipeptide is a central com-
ponent of the biosynthetic pathway and is produced by Ddl in an
ATP-dependent reaction mechanism which proceeds in two steps
(Parsons et al., 1988; Mullins et al., 1990). Although d-cycloserine has
long been known to inhibit Ddls and alanine racemase, problems
arising from the toxicity of the drug mean that its administration is
restricted (Neuhaus & Lynch, 1962) apart from the treatment of
Mycobacterium tuberculosis infections. Nevertheless, Ddls present an
attractive target for chemotherapeutic intervention because of their
essential and universal role in bacterial cell-wall formation.
The enterococcal homologue of EcDdlB, d-alanyl-d-alanine ligase
(VanA), functions in the mechanism of vancomycin resistance and
also represents a novel target in the reversal of vancomycin resistance
(Bugg et al., 1991). Therefore, the study of these enzymes is of prime
interest in the search for new antimicrobials, particularly by rational
drug-design methods. In order to elucidate the structural and
chemical basis of enzyme activity, the crystal structures of Ddl from
Escherichia coli (Fan et al., 1994), Staphylococcus aureus (Liu et al.,
2006), Thermus caldophilus (Lee et al., 2006),Helicobacter pylori (Wu
et al., 2008) and T. thermophilus HB8 (Kitamura et al., 2009) have
been reported. Additionally, the crystal structures of d-alanyl-
d-lactate ligases from Enterococcus faecium (Roper et al., 2000) and
Leuconostoc mesenteroides (Kuzin et al., 2000) have been reported.
EcDdlB represents one of the two isoforms of Ddl that exist in
E. coli and that have been kinetically characterized previously
(Zawadzke et al., 1991). Currently, two wild-type structures of E. coli
EcDdlB have been solved by X-ray crystallography in addition to a
mutant form, Y216F EcDdlB. The first of these represented the first
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structure of a Ddl to be solved (Fan et al., 1994) and is in complex
with ADP and a phosphophosphinate transition-state analogue. The
structure identified several active-site residues and formed the basis
for much of the subsequent work in the field of the Ddls (Shi &
Walsh, 1995; Park et al., 1996; Lessard et al., 1999; Prevost et al., 2000).
The subsequent structures of wild-type EcDdlB and Y216F EcDdlB
with phosphonate and phosphinate intermediates revealed no major
conformational changes in comparison to the first published structure
(Fan et al., 1997): both are in complex with a transition-state inter-
mediate and exist in closed enzyme conformations. Here, we report
the crystallization and preliminary characterization of EcDdlB in
complex with ATP and d-alanyl-d-alanine and in complex with ADP
and d-alanyl-d-alanine. d-Alanyl-d-alanine acts as a substrate for the
reverse reaction of ADP/Pi-dependent phosphorylysis, which occurs
at a Vmax of less than 1% of the forward reaction (Mullins et al., 1990).
EcDdlB has also previously been reported to display noncompetitive
product inhibition (with a reported Ki of 49 mM; Zawadzke et al.,
1991). This suggests that the mode of binding of d-alanyl-d-alanine to
the active site is different as a substrate and as an inhibitor, forming
the rationale for cocrystallization studies of EcDdlB with ATP and
d-alanyl-d-alanine. Furthermore, in contrast to previously reported
transition-state mimic-containing EcDdlB structures, crystallographic
studies of EcDdlB containing ADP and d-alanyl-d-alanine have been
performed in order to determine the true ternary complex structure
of EcDdlB. Further structural information regarding EcDdlB may
contribute to a greater structural understanding of EcDdlB and may
contribute to the design of effective ligase inhibitors.
2. Materials and methods
2.1. Cloning, overproduction and purification of E. coli EcDdlB
The gene for EcDdlB was amplified by PCR and cloned into the
NcoI and XhoI sites of pProEXa (Invitrogen) to produce an amino-
terminally histidine-tagged protein; the tag was not removed for
crystallization. Freshly transformed E. coli BL21(DE3)Star-
pRosetta cells harbouring pProEX::EcDdlB were grown in 1 l Luria
broth medium containing 50 mg ml1 ampicillin and 30 mg ml1
chloramphenicol. The culture was grown at 310 K to an OD600 of 0.5,
at which point isopropyl -d-1-thiogalactopyranoside was added to a
final concentration of 1 mM. After 3 h of induction at 310 K, cells
were harvested by centrifugation, resuspended in 30 ml buffer A
(50 mM sodium phosphate, 300 mM NaCl, 10 mM imidazole) and
sonicated. Cellular debris was removed by centrifugation at 20 000g
for 30 min and the supernatant was applied onto a 5 ml HisTrap Fast
Flow column (GE Healthcare) equilibrated with buffer A. EcDdlB
was eluted with a gradient of 10–250 mM imidazole over 60 ml.
The fractions containing EcDdlB were pooled, concentrated with a
Centripep-30 concentrator and applied onto a Superdex 200 column
equilibrated with 150 mM KCl, 50 mM HEPES pH 7.5 and 0.5 mM
EDTA. EcDdlB was eluted with approximately 180 ml buffer. The
fractions containing recombinant EcDdlB were analysed by SDS–
PAGE (Fig. 1), pooled and concentrated to 12 mg ml1 using a
Centriprep-30 concentrator. Enzyme activity was determined using a
continuous spectrometric assay monitoring ADP release as described
previously (Daub et al., 1988).
2.2. Crystallization
All crystallization experiments were performed using vapour
diffusion. Initial crystallization was performed using the sitting-drop
vapour-diffusion method. The protein concentration used for crys-
tallization was 12 mg ml1 in 5 mM ATP or 5 mM ADP and 50 mM
d-alanyl-d-alanine and a ratio of one volume of protein solution to
one volume of precipitant solution was used throughout. Crystals
were obtained in conditions from a commercially available crystal
screen (Molecular Dimensions). Refinement of the Tris–HCl condi-
tions from pH 8.5 to pH 8 using the hanging-drop vapour-diffusion
method gave crystals of sufficient quality for data collection.
2.3. Data collection
Single crystals of the EcDdlB complexes were flash-cooled in
liquid nitrogen using reservoir solution containing 30% glycerol as a
cryoprotectant. X-ray diffraction data were collected on beamline I04
at Diamond (UK). Diffraction images were measured using an ADSC
Quantum 315 CCD detector.
3. Results and discussion
The E. coli EcDdlB protein was purified by immobilized metal-
affinity chromatography and size-exclusion chromatography to yield
10 mg purified protein from 1 l culture. SDS–PAGE analysis revealed
that the preparation was free of major and minor contaminating
species. The subunit molecular mass on SDS–PAGE appeared to be
consistent with the calculated molecular mass of 34 533 Da. The
catalytic efficiency for d-alanyl-d-alanine synthesis was found to be
477.4  0.7 min1 mM1, a value that is comparable to that obtained
in a previous kinetic analysis of EcDdlB (440 min1 mM1) in a non-
histidine-tagged form (Park et al., 1996).
The best crystals were obtained at 291 K using the hanging-drop
method by mixing 1 ml protein solution containing 5 mM ATP or
50 mM ADP and 50 mM d-alanyl-d-alanine with 1 ml crystallization
solution containing 0.2M MgCl2, 25% PEG 3350, 0.1M Tris–HCl
pH 8.0 and equilibrating against a 500 ml reservoir. Crystals appeared
after 2 d as plates of dimensions of 0.1  0.35 mm (Figs. 2 and 3). We
are confident these crystals contained the ligands that were cocrys-
tallized since EcDdlB did not crystallize under the same conditions in
the apo form or with ATP, ADP or d-alanyl-d-alanine alone.
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Figure 1
12% SDS–PAGE analysis of the purification of EcDdlB. LaneMr, molecular-weight
standards (kDa); lane 1, crude cell lysate; lane 2, flowthrough from immobilized
metal-affinity chromatography; lane 3, peak from immobilized metal-affinity
chromatography; lane 4, peak from size-exclusion chromatography.
Initial diffraction experiments were carried out at the ESRF, but
complete data sets were collected to resolutions of 1.4 A˚ for EcDdlB–
ATP–d-alanyl-d-alanine and 1.5 A˚ for EcDdlB–ADP–d-alanyl-
d-alanine on the I04 beamline at the Diamond synchrotron (UK)
using an ADSC Q315 CCD detector with an oscillation angle of 1
and a crystal-to-detector distance of 160 mm. All data were indexed,
integrated and scaled using the HKL suite of programs (Otwinowski
& Minor, 1997). Data-collection and processing statistics are shown
in Table 1. For each data set, Matthews probability calculations
suggested the presence of two molecules in the asymmetric unit,
although a self-rotation function did not reveal the presence of a
noncrystallographic rotational axis (Matthews, 1968; Kantardjieff &
Rupp, 2003). A native Patterson map suggested the presence of
pseudo-translation, with a high peak in the (u, v, 12) Harker section
(94 and 31, corresponding to 40% and 13% of the origin-peak
height, for the two data sets, respectively). Molecular-replacement
solution using Phaser (McCoy et al., 2007) with the coordinates of the
Y216F EcDdlB mutant (PDB code 1i0w; Fan et al., 1997) as a model
subsequently revealed two molecules in the crystallographic asym-
metric unit which are related to each other by a twofold rotation
parallel to the z crystallographic axis for both data sets.
Models of the EcDdlB–ATP–d-alanyl-d-alanine complex and the
EcDdlB–ADP-d-alanyl-d-alanine complex are currently being built
and refined. We are also seeking to crystallize the protein in the apo
form and in complex with inhibitors. Ultimately, these studies may
contribute to further understanding of the individual reaction steps of
the mechanism, the activity-associated conformational changes and
the rational design of specific inhibitors against Ddls.
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Figure 3
Photograph of EcDdlB crystals obtained in the presence of ADP and d-alanyl-
d-alanine grown in 0.2M MgCl2, 25% PEG 3350, 0.1M Tris–HCl pH 8.0. The
approximate dimensions of the individual crystals are 0.1  0.4  0.02 mm.
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† Rmerge =
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hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith observa-
tion of reflection hkl and hI(hkl)i is the mean intensity of that reflection
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